Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
太平洋生物科技分析師評級的重要見解：你需要知道的
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB) in the last three months.
在過去三個月中，有11位分析師公佈了對太平洋生物科學（納斯達克股票代碼：PACB）的評級，提供了從看漲到看跌的不同視角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Pacific Biosciences, revealing an average target of $3.64, a high estimate of $8.00, and a low estimate of $2.00. A decline of 57.92% from the prior average price target is evident in the current average.
分析師爲太平洋生物科學設定了12個月的目標股價，顯示平均目標股價爲3.64美元，最高估計爲8.00美元，低估值爲2.00美元。目前的平均價格比先前的平均目標股價下降了57.92％。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析師評級：深度探索
The analysis of recent analyst actions sheds light...
對分析師近期行爲...
登入免費觀看全文
登入/註冊